readthroughSign in
CompanyONCONasdaqCincinnati, OH

Onconetix, Inc.

Onconetix develops Proclarix, an in vitro diagnostic test for prostate cancer approved in the European Union.

10-QNov 16Latest SEC filing
Nov 5Latest story